192 related articles for article (PubMed ID: 30076264)
41. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
[TBL] [Abstract][Full Text] [Related]
42. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
43. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Mijit M; Wireman R; Armstrong L; Gampala S; Hassan Z; Schneeweis C; Schneider G; Zhang C; Fishel ML; Kelley MR
Front Oncol; 2022; 12():826617. PubMed ID: 35402225
[TBL] [Abstract][Full Text] [Related]
44. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
[TBL] [Abstract][Full Text] [Related]
45. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract][Full Text] [Related]
46. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
Tell G; Damante G; Caldwell D; Kelley MR
Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
[TBL] [Abstract][Full Text] [Related]
47. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial APE1/Ref-1 suppressed protein kinase C-induced mitochondrial dysfunction in mouse endothelial cells.
Joo HK; Lee YR; Park MS; Choi S; Park K; Lee SK; Kim CS; Park JB; Jeon BH
Mitochondrion; 2014 Jul; 17():42-9. PubMed ID: 24861944
[TBL] [Abstract][Full Text] [Related]
49. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
50. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
Shah F; Logsdon D; Messmann RA; Fehrenbacher JC; Fishel ML; Kelley MR
NPJ Precis Oncol; 2017; 1():. PubMed ID: 28825044
[TBL] [Abstract][Full Text] [Related]
51. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
52. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
[TBL] [Abstract][Full Text] [Related]
53. Genistein alleviates radiation-induced pneumonitis by depressing Ape1/Ref-1 expression to down-regulate inflammatory cytokines.
Liu GD; Xia L; Zhu JW; Ou S; Li MX; He Y; Luo W; Li J; Zhou Q; Yang XQ; Shan JL; Wang G; Wang D; Yang ZZ
Cell Biochem Biophys; 2014 Jul; 69(3):725-33. PubMed ID: 24659138
[TBL] [Abstract][Full Text] [Related]
54. AQ4, an antitumor anthracenedione, inhibits endothelial cell proliferation and vascular endothelial growth factor secretion: implications for the therapy of ocular neovascular disorders.
Raghava S; Kompella UB
Eur J Pharmacol; 2007 Jul; 568(1-3):68-74. PubMed ID: 17543940
[TBL] [Abstract][Full Text] [Related]
55. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
56. Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.
Mantha AK; Dhiman M; Taglialatela G; Perez-Polo RJ; Mitra S
J Neurosci Res; 2012 Jun; 90(6):1230-9. PubMed ID: 22488727
[TBL] [Abstract][Full Text] [Related]
57. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
[TBL] [Abstract][Full Text] [Related]
58. Effects of interleukin-17 on human retinal vascular endothelial cell capillary tube formation in vitro.
Liu G; Wu H; Chen L; Xu J; Wang M; Li D; Lu P
Mol Med Rep; 2017 Jul; 16(1):865-872. PubMed ID: 28560397
[TBL] [Abstract][Full Text] [Related]
59. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
60. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets.
Yin X; Lin X; Ren X; Yu B; Liu L; Ye Z; Chen Q; Lee C; Lu W; Yu D; Li X
Pharmacol Res; 2019 Aug; 146():104277. PubMed ID: 31112749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
